Tristel (GB:TSTL) has released an update.
Tristel PLC has announced the appointment of Matthew Sassone as its new CEO, effective from September 2024, succeeding the company’s founder, Paul Swinney, after a competitive selection process. Sassone brings a wealth of experience from his previous senior leadership roles in the medical industry, including his time as Senior Vice-President Marketing at Masimo Corporation. His knowledge of the North American healthcare market is expected to boost Tristel’s global growth, especially in key markets like North America.
For further insights into GB:TSTL stock, check out TipRanks’ Stock Analysis page.
